Zuckerman Ilene H, Hernandez Jose Josue, Gruber-Baldini Ann L, Hebel J Richard, Stuart Bruce, Zimmerman Sheryl, Magaziner Jay
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA.
Am J Geriatr Pharmacother. 2005 Dec;3(4):246-54. doi: 10.1016/j.amjopharm.2005.12.007.
This study was designed to describe changes in the prevalence of potentially inappropriate medication prescribing before and after nursing home admission, and to compare prevalence among residents with and without dementia. This paper extends the research on inappropriate medication prescribing among residents entering a nursing home, with the added feature of comparison by dementia status.
This retrospective cohort study was conducted using data from 59 randomly selected nursing homes in Maryland. Dually eligible (Medicare/Medicaid) residents aged > or = 65 years who were admitted to one of these nursing homes from 1992 to 1995 were eligible for inclusion in the cohort. An expert panel of physicians determined dementia status at admission. Potentially inappropriate prescribing, as defined by the 1997 Beers criteria, was compared using Medicaid prescription claims for up to 12 months before and after admission to characterize monthly prescribing patterns.
The study group included 546 dually eligible nursing home residents with > or = 1 paid prescription claim for the 12 months before or after their admission date. A total of 372 (68%) residents were white, 443 (81%) were unmarried, 408 (75%) were female, and 334 (61%) were diagnosed with dementia at admission. Before nursing home admission, the mean monthly prevalence of potentially inappropriate medications for residents with and without dementia was 20% and 23%, respectively. After admission, the mean monthly prevalence increased to 28% among residents without dementia and decreased to 19% among residents with dementia. After adjusting for the mean number of other prescriptions, sociodemographic factors, and number of comorbid conditions, residents with dementia were as likely as residents without dementia to receive a potentially inappropriate drug before admission (prevalence ratio, 0.97; 95% CI, 0.58-1.62). After admission, residents with dementia were 27% less likely than residents without dementia to receive a potentially inappropriate drug, although the difference did not reach statistical significance (prevalence ratio, 0.73; 95% CI, 0.53-1.01).
Inappropriate medication prescribing was similar before nursing home admission among patients with and without dementia. After admission, the prevalence was lower among residents with dementia, but it did not reach statistical significance.
本研究旨在描述疗养院入院前后潜在不适当药物处方患病率的变化,并比较有痴呆症和无痴呆症居民之间的患病率。本文扩展了对进入疗养院的居民中不适当药物处方的研究,增加了按痴呆症状态进行比较的特点。
本回顾性队列研究使用了从马里兰州随机选取的59家疗养院的数据。1992年至1995年期间入住这些疗养院之一的年龄≥65岁的双重资格(医疗保险/医疗补助)居民有资格纳入该队列。一个医生专家小组确定入院时的痴呆症状态。使用入院前后长达12个月的医疗补助处方索赔来比较1997年《比尔斯标准》定义的潜在不适当处方,以描述每月的处方模式。
研究组包括546名双重资格的疗养院居民,他们在入院日期前后12个月内有≥1次付费处方索赔。共有372名(68%)居民为白人,443名(81%)未婚,408名(75%)为女性,334名(61%)在入院时被诊断患有痴呆症。在疗养院入院前,有痴呆症和无痴呆症居民的潜在不适当药物的平均每月患病率分别为20%和23%。入院后,无痴呆症居民的平均每月患病率升至28%,而有痴呆症居民的平均每月患病率降至19%。在调整了其他处方的平均数量、社会人口因素和合并症数量后,有痴呆症居民在入院前接受潜在不适当药物的可能性与无痴呆症居民相同(患病率比,0.97;95%置信区间,0.58 - 1.62)。入院后,有痴呆症居民接受潜在不适当药物的可能性比无痴呆症居民低27%,尽管差异未达到统计学显著性(患病率比,0.73;95%置信区间,0.53 - 1.01)。
有痴呆症和无痴呆症患者在疗养院入院前的不适当药物处方情况相似。入院后,有痴呆症居民的患病率较低,但未达到统计学显著性。